Please assess the completion status of the following clinical trial:

Trial Title: Post-Embolic Rhythm Detection With Implantable Versus External Monitoring

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of the index event\* made by a stroke specialist of an acute ischemic stroke or TIA occurring within the previous 90 days. The event must be either:~  1. an arterial ischemic stroke confirmed by neuroimaging; or~ 2. transient ischemic attack with diffusion weighted positive lesion on MRI~* At least one 12-lead ECG has already been obtained as part of the routine clinical post-stroke/TIA work-up, and no ECGs have shown any episodes of atrial fibrillation or atrial flutter~* The patient is being actively investigated for the etiology of the stroke/TIA event and additional cardiac monitoring is desired to screen further for the possibility of occult paroxysmal atrial fibrillation/flutter~* Age 18 years or older~* Informed consent from the patient~* The patient is expected to survive at least 6 months.~Exclusion Criteria:~* Any previously documented atrial fibrillation or atrial flutter, i.e. a past history of atrial fibrillation/flutter or atrial fibrillation/flutter detected on ECG, Holter, or telemetry following the index stroke/TIA event (a remote history of transient perioperative atrial fibrillation is not exclusionary)~* Planned carotid endarterectomy or carotid artery stenting within 90 days~* Any condition for which there is already an indication for long term anticoagulation Pacemaker or implantable cardioverter defibrillator device~* Work-up for stroke that has already included extended (\>48 hour) external ECG (excluding telemetry)~* Stroke and/or comorbid illness will prevent completion of planned follow-up assessments

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Implanted Loop Recorder (Type: EXPERIMENTAL): long-term implantable ECG (Medtronic Reveal LINQ) coupled with remote monitoring (MyCareLink) for 12 months
- External Loop Recorder (Type: EXPERIMENTAL): external event-triggered ECG loop recorder (Sorin Spiderflash-t) for 30 days

Based on this trial design, predict the completion outcome and termination type (if applicable).